6505--Lenalidomide VISN 22 BPA

Active

Contract Opportunity

THIS REQUEST FOR INFORMATION (RFI) /Â SOURCES SOUGHT NOTICE IS ISSUEDÂ SOLELY FOR INFORMATION AND PLANNING PURPOSES. THIS IS NOT A SOLICITATION.
SUBMISSION OF INFORMATION ABOUT PRICING, DELIVERY, THE MARKET, AND CAPABILITIES IS HIGHLY ENCOURAGED AND ALLOWED UNDER THIS RFI FOR PLANNING PURPOSES IN ACCORDANCE WITH (IAW) FAR 15.201(e).
DISCLAIMER
This RFI is issued solely for information and planning purposes and does not constitute a solicitation. All information received in response to this RFI that is marked as proprietary will be handled accordingly. IAW FAR 15.201(e), responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this RFI.
SOURCES SOUGHT/RFI DESCRIPTION
This is NOT a solicitation announcement. This is a Sources Sought Notice / RFI only. The purpose of this Sources Sought Notice / RFI is to gain information about potential qualified sources and their size classification relative to NAICS 325412 (size standard of 1,300 Employees). Responses to this Sources Sought Notice / RFI will be used by the Government to make appropriate acquisition decisions. After review of the responses to this Sources Sought Notice / RFI, further RFIs and/or a solicitation or other announcements may be published.
The Department of Veterans Affairs (VA) is seeking sources capable of providing Lenalidomide medication.
STATEMENT OF WORK
LENALIDOMIDE MEDICATION

Introduction
The Department of Veterans Affairs requires a Veterans Integrated Service Network (VISN) 22 Blanket Purchase Agreement (BPA) for Lenalidomide. Lenalidomide is an oral immunomodulatory medication that treats several types of blood cancers. Contractor is to provide Lenalidomide and deliver to participating VISN 22 VA Medical Centers (VAMCs).

Participating VAMCs:

VA Albuquerque Healthcare System (501)
1501 San Pedro Drive SE
Albuquerque, NM 87108

VA Long Beach Healthcare System (600)
5901 East 7th Street
Long Beach, CA 90822

VA Loma Linda Healthcare System (605)
11201 Benton Street
Loma Linda, CA 92357

VA Phoenix Healthcare System (644)
650 E Indian School Road
Phoenix, AZ 85012

VA Prescott Healthcare System (649)
500 N. State Highway 89
Prescott, AZ 86313

VA San Diego Healthcare System (664)
3350 La Jolla Village Drive
San Diego, CA 92161

VA Tucson Healthcare System (678)
3601 S 6th Avenue
Tucson, AZ 85723

VA Greater Los Angeles Healthcare System (691)
11301 Wilshire Blvd
Los Angeles, CA 90073

Ordering
Participating VA Medical Centers shall place orders through an approved purchase order (PO) per station. An approved purchase order shall be signed by a warranted Contracting Officer (CO).

Dispensing:
Lenalidomide is under Food and Drug Administration s Risk Evaluation and Mitigation Strategy (REMS) program. The contractor must hold REMS certification to dispense.

Schedule of Supplies:
Line Item
Description
0001
LENALIDOMIDE 2.5MG CAP,ORAL
0002
LENALIDOMIDE 5MG CAP,ORAL
0003
LENALIDOMIDE 10MG CAP,ORAL
0004
LENALIDOMIDE 15MG CAP,ORAL
0005
LENALIDOMIDE 20MG CAP,ORAL
0006
LENALIDOMIDE 25MG CAP,ORAL

Station
Estimated number of patients on FY 26
501
14
600
27
605
18
644
32
649
13
664
28
678
30
691
26

There is not a contractual statement of precise quantities that the Government will order under this BPA. The Government will only pay for quantities that are actually ordered and for which services are fulfilled of each delivery order per station.

Above estimated number for patients is based on historical data from previous years. As the required dosage will vary depending on individual patient and provider decisions, the Government is unable to specify the exact quantity needed for each dosage. The contractor is to provide pricing for all dosage strengths, and each station will place orders as needed at the prices negotiated under this contract.

Period of Performance: 1-year after award

Delivery:
The contractor shall be responsible for the delivery of medication to specified location upon ordering in accordance with the requirements outlined.
The medication should be provided in the required quantities and formulation as specified.
The contractor must ensure proper handling, storage, and transportation conditions (temperature control if required) of the medication to maintain its integrity and compliance with all applicable regulations.

Payments:
Payments shall be made upon delivery and acceptance by individual medical centers. The contractor shall use the purchase order (PO) number when submitting for payment through Tungsten network website https://portal.tungsten-network.com.

The list of DRAFT characteristics is intended to be descriptive, not restrictive, of the supplies/services that are required.
If your company is interested and capable of providing the required supplies/services, please provide the information indicated below. Response to this notice should include company name, address, point of contact, size of business pursuant to the following questions:
(1) Submit your capabilities statement illustrating how your organization can/cannot meet the list of SOW requirements. For instances where your company cannot meet the SOW requirement(s), please explain. For instances where your company can meet the SOW requirement(s), please show how your company meets/exceeds each requirement.
(2) Please review the list of SOW requirements and provide any additional feedback or suggestions. If none, please reply as N/A.
(3) Please indicate the size status and representations of your business, such as but not limited to: Service-Disabled Veteran-Owned Small Business (SDVOSB), Veteran-Owned Small Business (VOSB), HUBZone, Woman Owned Small Business (WOSB), Large Business, etc.
(4) Is your company considered small under the NAICS code identified in this RFI?
(5) Are you the manufacturer, authorized distributor, and/or can your company provide a solution to the required supplies/services described in the list of SOW?
(6) If you are a large business, do you have any designated/authorized distributors? If so, please provide their company name, telephone, point of contact and size status (if available).
(7) If you re a small business and you are an authorized distributor/reseller for the items identified above, do you alter; assemble; modify; the items requested in any way? If you do, state how and what is altered; assembled; modified.
(8) Limitations on Subcontracting: How does your business ensure compliance with the limitations on subcontracting as outlined in 13 CFR § 125.6?
(9) Are the items you are identifying/providing considered Commercial of the Shelf (COTS) items as defined in FAR Part 2.101 under commercial items?
(10) Non-Manufacturer Rule: If applicable, can you confirm your business complies with the Non-Manufacturer rule? Specifically, does your company: Provide a product from a small business manufacturer or processor? Not exceed 500 employees? Primarily engage in the retail or wholesale trade and normally sell the type of item being supplied? Take ownership or possession of the item(s) with its personnel, equipment or facilities in a manner consistent with industry practice?
(11) Please indicate whether your product conforms to the requirements of the Buy American Act?
(12) What is your lead time to deliver a single unit with all components? Is there scale in lead time with greater quantities? Please elaborate.
(13) What is estimated life span of your solution? What support/services does that entail?
(14) Does your proposed equipment have FDA clearance? Please specify what FDA clearance(s) have been obtained.
(15) Does your organization offer a leasing solution? Please elaborate.
(16) Does your company have a Federal Supply Schedule (FSS) GSA/NAC/SAC/BPA/NASA SEWP or any other Federal Government contract? If so, please provide the contract number(s).
(17) If you are an FSS GSA/NAC/SAC/BPA/NASA SEWP or any other Federal Government contract holder, are all the items/solutions you are providing information about available on your schedule/contract? Please state if all or some items are available on the contract.
(18) General pricing of your products/solution is encouraged. Pricing will be used for the purpose of market research only. It will not be used to evaluate for any type of award.
(19) Please provide your SAM.gov Unique Entity ID/Cage Code number.
Responses to this notice shall be submitted via email to Hestia.Sim@va.gov. Telephone responses will not be accepted. Responses must be received no later than Friday, October 31, 2025, by 10AM Pacific Local Time.
All responses to this Sources Sought/RFI will be used for planning purposes only. Responses to this Sources Sought Notice / RFI are not considered a request to be added to a prospective bidders list or to receive a copy of the solicitation. If further RFIs and/or a solicitation or other announcement is issued as a result of the information provided from this RFI, all interested parties must respond to the specific posting separately IAW the specifications of that announcement.

Attachments/Links